There are a few reports (Table 1) on salvage surgery after a response to EGFR-TKIs in patients with advanced NSCLC; however, the treatment has not been validated from either a surgical or an oncologic point of view. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.